Impact Fusion International, Inc.

Impact Fusion International, Inc. engages in the business of marketing products in the health and wellness sector. The company focuses on the invention, development, and marketing of its proprietary products worldwide for the health of humans and animals. The company's products include Nutri-Mastic that supports digestive function, the immune system, vital organ health, healthy blood cells, and cardiac muscle and heart function; Intact Nutrition herbal health support products; Intact Endurance, which offers nutrients to increase body's optimal energy levels; Pet Intact nutritional supplements; and Equine Intact products. It also sells herbal health support beverages under the Mastic Blast Beverage brand; and alternative proprietary formulation for beef and dairy cattle under the Supreme Gold Plus brand. The company was formerly known as Red Reef Laboratories International, Inc. and changed its name to Impact Fusion International Inc. in April 2009. Impact Fusion International, Inc. was founded in 2002 and is based in Margate, Florida.

Impact Fusion International, Inc. trades as IFUS on OTC. The company is classified in Communication Services / Advertising Agencies and reports in USD.

The current profile places the business in Advertising Agencies. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $211,130 of revenue and $62,812 of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Impact Fusion International, Inc. can be compared against peers such as Axtel, S.A.B. de C.V., CFN Enterprises Inc., Emmis Corporation, Kidoz Inc., Mobiquity Technologies, Inc., OverActive Media Corp..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $21.98M, beta of 3.02, and return on equity of +542.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

IFUS currently shows total debt of $721,376 and beta of 3.02. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: http://impactfusionbrands.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.